Clustering of metabolic abnormalities in obese individuals: the role of genetic factors

References

• Ferrannini E. Syndrome X. Horm Res 1993; 39: 107–11, (Suppl 3)
   PubMedGoogle Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
   PubMed Web of Science ®Google Scholar
• Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridaemia, and hypertension. Arch Intern Med 1989; 149: 1514–20
   PubMed Web of Science ®Google Scholar
• Björntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992; 24: 465–8
   PubMed Web of Science ®Google Scholar
• Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995; 19: S52–9, (Suppl 1)
   Google Scholar
• Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances in diabetes mellitus. Lancet 1963; 1: 785–9
   PubMed Web of Science ®Google Scholar
• Belfiore F, Iannello S. Insulin resistance in obesity: Metabolic mechanisms and measurement methods. Mol Genet Metab 1998; 65: 121–8
   PubMed Web of Science ®Google Scholar
• Bergman RN, Mittelman SD. Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol 1998; 9: 205–21
   PubMedGoogle Scholar
• Pouliot MC, Després JP, Nadeau A, Tremblay A, Moorjani S, Lupien PJ. Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women. Int J Obes 1990; 14: 293–302
   PubMedGoogle Scholar
• Frayn KN. Visceral fat and insulin resistance-causative or correlative. Br J Nutr 2000; 83: S71–7
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579–85
   PubMed Web of Science ®Google Scholar
• Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88–98
   PubMed Web of Science ®Google Scholar
• Imbeault P, Lemieux S, Prud'homme D, Tremblay A, Nadeau A, Després JP. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy. Metabolism 1999; 48: 355–62
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. on behalf of the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 1997; 100: 1166–73
   PubMed Web of Science ®Google Scholar
• Despres J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 1992; 113: 151–69
   PubMedGoogle Scholar
• Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 119–25
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271–8
   PubMed Web of Science ®Google Scholar
• Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel. Curr Opin Lipidol 1996; 7: 241–53
   PubMed Web of Science ®Google Scholar
• Muller-Wieland D, Kotzka J, Knebel B, Krone W. Metabolic syndrome and hypertension: pathophysiology and molecular basis of insulin resistance. Basic Res Cardiol 1998; 93: 131–4, (Suppl 2)
   PubMedGoogle Scholar
• Björntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 1999; 16: 373–83
   PubMed Web of Science ®Google Scholar
• Björntorp P, Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci 1999; 892: 297–307
   PubMed Web of Science ®Google Scholar
• Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 671–80
   PubMed Web of Science ®Google Scholar
• Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997; 46: 313–6
   Web of Science ®Google Scholar
• Van Gaal LF, Wauters MA, Mertens IL, Considine RV, De Leeuw IH. Clinical endocrinology of human leptin. Int J Obes Relat Metab Disord 1999; 23: 29–36, (Suppl 1)
   PubMedGoogle Scholar
• De Courten M, Zimmet P, Hodge A, Collins V, Nicholson M, Staten M. Hyperleptinaemia: the missing link in the metabolic syndrome. Diabet Med 1997; 14: 200–8
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endrocr Rev 1999; 20: 649–88
   PubMed Web of Science ®Google Scholar
• Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999; 354: 141–8
   PubMed Web of Science ®Google Scholar
• Kruszynska YT, Mukherjee R, Jow L, Dana S, Paterniti JR, Olefsky JM. Skeletal muscle peroxisome proliferator-activated receptor-gamma expression in obesity and non-insulin-dependent diabetes mellitus. J Clin Invest 1998; 101: 543–8
   PubMedGoogle Scholar
• Loviscach M, Rehman N, Carter L, Mudaliar S, Mohadeen P, Ciaraldi TP. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia 2000; 43: 304–11
   PubMed Web of Science ®Google Scholar
• Martin G, Schoonjans K, Staels B, Auwerx J. PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 1998; 137: S75–80
   Web of Science ®Google Scholar
• Bouchard C, Perusse L. Genetics of causes and manifestations of the metabolic syndrome. 6th European Symposium on metabolism: the plurimetabolic syndrome, Crepaldi G. Elsevier Science Publishers;, Padova, Amsterdam 1994
   Google Scholar
• Nelson TL, Vogler GP, Pedersen NL, Hong Y, Miles TP. Genetic and environmental influences on body fat distribution, fasting insulin levels and CVD: are the influences shared. Twin Research 2000; 3: 43–50
   PubMedGoogle Scholar
• Snieder H, Boomsma DI, van Doornen LJ, Neale MC. Bivariate genetic analysis of fasting insulin and glucose levels. Genet Epidemiol 1999; 16: 426–46
   PubMed Web of Science ®Google Scholar
• Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L. Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia 2000; 43: 285–93
   PubMed Web of Science ®Google Scholar
• Narkiewicz K, Chrostowska M, Kuchta G, Szczech R, Welz A, Rynkiewicz A. Genetic influences on insulinemia in normotensive twins. Am J Hypertens 1997; 10: 467–70
   PubMedGoogle Scholar
• Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Schmidt MI. Familial components of the multiple metabolic syndrome: the ARIC Study. Diabetologia 1997; 40: 963–70
   PubMedGoogle Scholar
• Carmelli D, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: Same genes or same environments. Am J Hum Genet 1994; 55: 566–73
   PubMed Web of Science ®Google Scholar
• Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA 1991; 265: 2079–84
   PubMed Web of Science ®Google Scholar
• Mitchell BD, Kammerer CM, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD. Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 1996; 16: 281–8
   PubMedGoogle Scholar
• Hong Y, Pedersen NL, Brismar K, de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 1997; 60: 143–52
   PubMedGoogle Scholar
• Mayer EJ, Newman B, Austin MA, Zhang D, Quesenberry CP, Jr, Edwards K. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am J Epidemiol 1996; 143: 323–32
   PubMedGoogle Scholar
• Rice T, Province M, Pérusse L, Bouchard C, Rao DC. Cross-trait familial resemblance for body fat and blood pressure: familial correlations in the Quebec Family Study. Am J Hum Genet 1994; 55: 1019–29
   PubMedGoogle Scholar
• Rice T, Nadeau A, Pérusse L, Bouchard C, Rao DC. Familial correlations in the Quebec Family Study: cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia 1996; 39: 1357–64
   PubMedGoogle Scholar
• Pérusse L, Rice T, Després JP, Rao DC, Bouchard C. Cross-trait familial resemblance for body fat and blood lipids: Familial correlations in the Quebec Family Study. Arterioscler Thromb Vase Biol 1997; 17: 3270–7
   PubMedGoogle Scholar
• Hong Y, Rice T, Gagnon J, Després JP, Nadeau A, Pérusse L. Familial clustering of insulin and abdominal visceral fat: The HERITAGE Family Study. J Clin Endocrinol Metab 1998; 83: 4239–45
   PubMedGoogle Scholar
• An P, Rice T, Gagnon J, Leon AS, Skinner JS, Wilmore JH. Cross-trait familial resemblance for resting blood pressure and body composition and fat distribution: The HERITAGE Family Study. Am J Hum Biol 2000; 12: 32–41
   PubMedGoogle Scholar
• Pedersen O. Genetics of insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 113–8
   PubMed Web of Science ®Google Scholar
• Orho-Melander M, Almgren P, Kanninen T, Forsblom C, Groop LC. A paired-sibling analysis of the Xbal polymorphism in the muscle glycogen synthase gene. Diabetologia 1999; 42: 1138–45
   PubMedGoogle Scholar
• Groop LC, Kankuri M, Schalin-Jäntti C, Ekstrand A, Nikula-Ijäs P, Widen E. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes. N Engl J Med 1993; 328: 10–4
   PubMed Web of Science ®Google Scholar
• Shimomura H, Sanke T, Ueda K, Hanabusa T, Sakagashira S, Nanjo K. A missense mutation of the muscle glycogen synthase gene (M416 V) is associated with insulin resistance in the Japanese population. Diabetologia 1997; 40: 947–52
   PubMedGoogle Scholar
• Schalin-Jäntti C, Nikula-Ijäs P, Huang X, Lehto M, Knudsen P, Syvänne M. Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects. Hypertension 1996; 27: 67–71
   PubMedGoogle Scholar
• Chiu KC, Chuang LM, Ryu JM, Tsai GP, Saad MF. The I27L amino acid polymorphism of hepatic nuclear factor-1 alpha is associated with insulin resistance. J Clin Endocrinol Metab 2000; 85: 2178–83
   PubMedGoogle Scholar
• Ukkola O, Garenc C, Pérusse L, Bergeron J, Després J-P, Rao DC. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Quebec Family Study. Atherosclerosis, (in press)
   Google Scholar
• Klannemark M, Orho M, Langin D, Laurell H, Holm C, Reynisdottir S. The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity. Diabetologia 1998; 41: 1516–22
   Google Scholar
• Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, Bozzali M. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 1999; 48: 1881–4
   PubMed Web of Science ®Google Scholar
• Weaver JU, Kopelman PG, Hitman GA. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′flanking region of the human insulin gene. Eur J Clin Invest 1992; 22: 265–70
   PubMedGoogle Scholar
• Morris BJ. Insulin receptor gene in hypertension. Clin Exp Hypertens 1997; 19: 551–65
   PubMed Web of Science ®Google Scholar
• Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J. A Pro12A1a substitution in PPAR gamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284–7
   PubMed Web of Science ®Google Scholar
• Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339: 953–9
   PubMed Web of Science ®Google Scholar
• Mauriege P, Bouchard C. Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 1996; 348: 698–9
   PubMedGoogle Scholar
• Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995; 95: 1281–7
   PubMed Web of Science ®Google Scholar
• Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996; 271: 10892–6
   PubMed Web of Science ®Google Scholar
• Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993; 42: 514–9
   PubMed Web of Science ®Google Scholar
• Mitchell BD, Kammerer CM, O'Connell P, Harrison CR, Manire M, Shipman P. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes 1995; 44: 1046–53
   PubMed Web of Science ®Google Scholar
• Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997; 40: 706–10
   PubMed Web of Science ®Google Scholar
• Buemann B, Vohl M-C, Chagnon M, Chagnon YC, Gagnon J, Pérusse L. Abdominal visceral fat is associated with a Bell restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 1997; 5: 186–92
   PubMedGoogle Scholar
• Rosmond R, Chagnon YC, Holm G, Chagnon M, Pérusse L, Lindell K. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 2000; 8: 211–8
   PubMedGoogle Scholar
• Weaver JU, Hitman GA, Kopelman PG. An association between a Bell restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol 1992; 9: 295–300
   PubMed Web of Science ®Google Scholar
• Ukkola O, Rankinen T, Weisnagel SJ, Sun G, Perusse L, Chagnon YC. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 2000; 49: 1063–70
   PubMedGoogle Scholar
• Ukkola O, Pérusse L, Chagnon YC, Després J-P, Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes Relat Metab Disord, (in press)
   Google Scholar
• Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10: 473–82
   PubMed Web of Science ®Google Scholar
• Rosmond R, Chagnon YC, Chagnon M, Perusse L, Bouchard C, Bjorntorp P. A polymorphism of the 5′flanking region of the glucocorticoid receptor gene locus is associated with basal Cortisol secretion in men. Metabolism 2000; 49: 1197–9
   PubMedGoogle Scholar
• Rankinen T, Gagnon J, Pérusse L, Rice T, Leon AS, Skinner JS. Body fat, resting and exercise blood pressure and the angiotensinogen M235T polymorphism: the HERITAGE Family Study. Obes Res 1999; 7: 423–30
   PubMedGoogle Scholar
• Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000; 85: 3126–31
   PubMed Web of Science ®Google Scholar
• Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 1996; 94: 2171–6
   PubMedGoogle Scholar
• Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin. Thromb Haemost 1989; 61: 370–3
   PubMed Web of Science ®Google Scholar
• Humphries SE, Green FR, Temple A, Dawson S, Henney A, Kelleher CH. Genetic factors determining thrombosis and fibrinolysis. Ann Epidemiol 1992; 2: 371–85
   PubMedGoogle Scholar
• Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes 1995; 44: 37–42
   PubMed Web of Science ®Google Scholar
• Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo O. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiotensin converting enzyme (ACE) genes. Arterioscler Thromb Vase Biol 1997; 17: 2082–7
   PubMedGoogle Scholar
• Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468–72
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Vendrell J, Ricart W, Broch M, Gutierrez C, Casamitjana R. Polymorphism of tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care 2000; 23: 831–7
   PubMed Web of Science ®Google Scholar
• Pouliot M-C, Despres J-P, Moorjani S, Lupien PJ, Tremblay A, Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 1990; 31: 1023–9
   PubMedGoogle Scholar
• Després J-P, Verdon M-F, Moorjani S, Pouliot M-C, Nadeau A, Bouchard C. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes 1993; 42: 1474–81
   PubMedGoogle Scholar
• Sijbrands EJ, Hoffer MJ, Meinders AE, Havekes LM, Frants RR, Smelt AH. Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism. Arterioscler Thromb Vase Biol 1999; 19: 2722–9
   PubMedGoogle Scholar
• Vohl M-C, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vase Biol 1995; 15: 714–20
   PubMedGoogle Scholar
• Vohl M-C, Lamarche B, Bergeron J, Moorjani S, Prud'homme D, Nadeau A. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity. Atherosclerosis 1997; 128: 183–90
   PubMedGoogle Scholar
• Pouliot M-C, Després J-P, Dionne FT, Vohl M-C, Moorjani S, Prud'homme D. ApoB-100 Gene EcoRI polymorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb 1994; 14: 527–33
   PubMedGoogle Scholar
• Vohl M-C, Tchernof A, Dionne FT, Moorjani S, Prud'homme D, Bouchard C. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men. Diabetes 1996; 45: 1405–11
   PubMedGoogle Scholar
• Vohl MC, Lamarche B, Pascot A, Leroux G, Prud'homme D, Bouchard C. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome. Int J Obes Relat Metab Disord 1999; 23: 918–25
   PubMedGoogle Scholar
• Zee RY, Griffiths LR, Morris BJ. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives. Biochem Biophys Res Commun 1992; 189: 965–71
   PubMed Web of Science ®Google Scholar
• Bouchard C, Tremblay A, Després J-P, Nadeau A, Lupien PJ, Thériault G. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477–82
   PubMed Web of Science ®Google Scholar
• Oppert J-M, Nadeau A, Tremblay A, Després J-P, Thériault G, Dériaz O. Plasma glucose, insulin, and glucagon before and after long-term overfeeding in identical twins. Metabolism 1995; 44: 96–105
   PubMed Web of Science ®Google Scholar
• Ukkola O, Tremblay A, Després J-P, Chagnon YC, Campfield LA, Bouchard C. Leptin receptor G1n223Arg variant is associated with a cluster of metabolic abnormalities in response to long-term overfeeding. J Intern Med 2000; 248: 435–9
   PubMedGoogle Scholar
• Ukkola O, Rosmond R, Tremblay A, Bouchard C. Glucocorticoid receptor Bel I variant is associated with increased atherogenic profile in response to long-term overfeeding. Atherosclerosis, (in press)
   Google Scholar
• Wilmore JH, Després J-P, Stanforth PR, Mandel S, Rice T, Gagnon J. Alterations in body weight and composition consequent to 20 wk of endurance training: the HERITAGE Family Study. Am J Clin Nutr 1999; 70: 346–52
   PubMed Web of Science ®Google Scholar
• Pérusse L, Rice T, Province MA, Gagnon J, Leon AS, Skinner JS. Familial aggregation of amount and distribution of subcutaneous fat and their responses to exercise training in the HERITAGE family study. Obes Res 2000; 8: 140–50
   PubMedGoogle Scholar
• Sun G, Gagnon J, Chagnon YC, Pérusse L, Després J-P, Leon AS. Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int J Obes Relat Metab Disord 1999; 23: 929–35
   PubMedGoogle Scholar
• Rankinen T, Gagnon J, Pérusse L, Chagnon YC, Rice T, Leon AS. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279: H368–74
   Google Scholar
• Ukkola O, Pérusse L, Weisnagel SJ, Bergeron J, Després J-P, Rao DC. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and plasma insulin and lipid levels in the Quebec Family Study. Metabolism 2001; 50: 246–52
   PubMedGoogle Scholar